SUN-739 Next Generation AR Antagonists Increase Systemic Active Glucocorticoid Exposure by Altering Glucocorticoid Metabolism

Enzalutamide and apalutamide are potent next-generation androgen receptor (AR) antagonists used in metastatic and non-metastatic prostate cancer. Despite the increased survival benefits of these agents, resistance normally occurs and the disease transitions to its lethal form. We hypothesized that e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Alyamani, Mohammad, Sharifi, Nima, Li, Jianbo, Patel, Mona, Berk, Michael, Taylor, Susan, Przybycin, Christopher, Posadas, Edwin M, Madan, Ravi, Gulley, James L, Rini, Brian I, Garcia, Jorgi A, Klein, Eric A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Steroid Hormones and Receptors
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208944/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados